Close

Rick Davis

Senior Director, New Ventures and Transactions, Oncology

Rick is Senior Director, New Ventures and Transactions, Oncology at Johnson & Johnson Innovation, London .  In this role, Rick leverages his experience and knowledge of the scientific and biotech landscape to identify and evaluate external opportunities and deliver transformative innovation into the pipeline.
 
Rick has over 17 years of experience in the life sciences sector. Before joining Johnson & Johnson he was the Chief Executive Officer of a European clinical stage biotech company, Trino Therapeutics. Previously, he held a number of key positions at the Wellcome Trust. He was responsible for maximising financial returns on direct healthcare investments in both private and public equities and venture capital funds in their Investment Division.  During this time he was on the board of directors of a number of biotech companies and worked closely with management teams on strategy, financing and exits via M&A and public listings.
 
Prior to this role, Rick was in Business Development where he established and managed a large corporate venture fund, building an extensive external pipeline of preclinical pharmaceutical assets sourced from EU and US academic and biotech labs. After a obtaining a PhD in pharmacology, he started his career in the biotechnology industry at Pharmagene where he helped to establish their therapeutics division and led multi-disciplinary teams in drug development and contract research.

Email

Rick Davis
Rick Davis